Clinical trial

Vasopressor Agents in Pulmonary Hypertension Crisis

NCT07667829

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-06-01

PhaseNA

Study timeline

Study start (estimated)2026-06-01Date precision: month

Registry last updated2026-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertension (PAH)unresolved

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)unresolved

Hypertension, Pulmonaryunresolved

Interventions

NorepinephrineDRUG · verified · RxNorm: norepinephrine

DopamineDRUG · verified · RxNorm: dopamine

EpinephrineDRUG · verified · RxNorm: epinephrine

Sponsors & collaborators

China National Center for Cardiovascular Diseaseslead sponsor

Mapped research locations

BeijingBeijing Municipality, China1 GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07667829 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.